Intellia Therapeutics Announces Positive Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002 for the Treatment of Hereditary Angioedema (HAE)
September 16, 2022 07:00 ET
|
Intellia Therapeutics, Inc.
Positive interim clinical data further validate the modularity of Intellia’s industry-leading genome editing platform and its potential to target a multitude of genetic diseases A single dose of...
Worldwide CRISPR Industry to 2028 - by Application, End-user and Region
September 15, 2022 07:53 ET
|
Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Global CRISPR Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global CRISPR market is anticipated to grow at a...
Genome Editing Market to Hit $21.36 Billion by 2030, With a CAGR of 17.33% Asserts Strategic Market Research
September 12, 2022 08:30 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, USA, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The Global Genome Editing Market was USD 5.06 Billion in 2021 and will reach USD 21.36 Billion in 2030 at a 17.33% CAGR. Genome editing, also known...
Genomics Global Market to Reach $63.5 Billion in 2026 at a CAGR of 18.2%
September 06, 2022 07:08 ET
|
Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Genomics Global Market Report 2022, By Product Type, By Process, By End User" report has been added to ResearchAndMarkets.com's offering. The global...
Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
August 15, 2022 23:41 ET
|
Endure Biotherapeutics, Inc.
San Diego, Aug. 15, 2022 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics Zarrinpar...
Global CRISPR Gene Detection and Diagnostic Market Research Report 2022: Cost, Accuracy and Speed, The Economies of Multiplexing with Nucleic Acids, The New Agriculture, Pandemics and Pathogens
July 27, 2022 06:08 ET
|
Research and Markets
Dublin, July 27, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides"...
Insights on the Genome Editing Global Market to 2027 - Growing Cases of Cancer and Other Genetic Disorders is Driving Growth
June 22, 2022 06:03 ET
|
Research and Markets
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. Genome editing is a method of making...
Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its CRISPR-Engineered Allogeneic Platform at the 2022 Keystone Symposia’s Precision Genome Engineering Conference
May 02, 2022 07:30 ET
|
Intellia Therapeutics, Inc.
Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for TCR-T and CAR-T cell therapyFindings support recent development candidate...
Rat Model Market revenue worth USD 2.3 Billion by 2028, Says Global market insights inc.
April 26, 2022 05:15 ET
|
Global Market Insights Inc.
Selbyville, Delaware, April 26, 2022 (GLOBE NEWSWIRE) -- The rat model market value is projected to reach USD 2.3 billion by 2028, according to a new research report by Global Market Insights Inc....
Global CRISPR Technology Market Analysis 2022-2026, Featuring Profiles of Thermo Fisher Scientific, CRISPR Therapeutics, GenScript Biotech, Editas Medicine and Intellia Therapeutics
April 19, 2022 04:08 ET
|
Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering....